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A B S T R A C T   
Cardiosphere-derived cells (CDCs) encapsulated within alginate-poly-L-lysine-alginate (APA) microcapsules 
present a promising treatment alternative for myocardial infarction. However, clinical translatability of encap-
sulated CDCs requires robust long-term preservation of microcapsule and cell stability, since cell culture at 37 ◦C 
for long periods prior to patient implantation involve high resource, space and manpower costs, sometimes 
unaffordable for clinical facilities. Cryopreservation in liquid nitrogen is a well-established procedure to easily 
store cells with good recovery rate, but its effects on encapsulated cells are understudied. In this work, we assess 
both the biological response of CDCs and the mechanical stability of microcapsules after long-term (i.e., 60 days) 
cryopreservation and compare them to encapsulated CDCs cultured at 37 ◦C. We investigate for the first time the 
effects of cryopreservation on stiffness and topographical features of microcapsules for cell therapy. Our results 
show that functionality of encapsulated CDCs is optimum during 7 days at 37 ◦C, while cryopreservation seems to 
better guarantee the stability of both CDCs and APA microcapsules properties during longer storage than 15 days. 
These results point out cryopreservation as a suitable technique for long-term storage of encapsulated cells to be 
translated from the bench to the clinic.   
1. Introduction 
Cell-based regenerative therapies are emerging as a promising 
strategy for the treatment of myocardial infarction (Ghiroldi et al., 2018; 
Tompkins et al., 2018). Among them, the use of cardiosphere-derived 
cells (CDCs) which produce growth factors involved in myocardial 
regeneration (Chimenti et al., 2010), has shown promising results in 
both preclinical and clinical trials (Makkar et al., 2012; Yee et al., 2014). 
Delivery of CDCs, or its secretions, reduces fibrotic scar size and miti-
gates microvascular obstruction, adverse remodelling and ventricular 
dilatation; improving myocardium viability and general cardiac func-
tion in porcine models of ischemic cardiomyopathy and myocardial 
infarction (Gallet et al., 2017; Kanazawa et al., 2015; Yee et al., 2014). 
Despite successful CDCs delivery without host immunological response 
to graft (Blázquez et al., 2016), heartbeat motions typically result in 
continuous mechanical displacement of CDCs, thereby compromising 
the survival and engraftment rate of transplanted cells (Van Ramshorst 
et al., 2011). 
CDCs microencapsulation is an interesting strategy to improve cell 
engraftment. Microencapsulation of therapeutic cells aims to preserve 
cells within a biocompatible hydrogel that allows exchange of nutrients 
and cell therapeutic products via diffusion, while avoiding foreign im-
mune recognition (Farina et al., 2019; Lim and Sun, 1980). In myocar-
dial infarction treatments, the bigger size of microcapsules, compared 
with individual cells, prevents microcapsule washout from myocardium 
into the bloodstream caused by the cardiac contractile forces (Al Kindi 
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et al., 2011; Paul et al., 2009). The success of microencapsulation for cell 
therapy requires an adequate microenvironment for encapsulated cell 
viability and compound diffusion, and a stable, biocompatible and non- 
immunogenic polymer surface. Suitable mechanical resistance is also 
desirable to prevent breakage and release of microcapsule contents 
(Ciriza et al., 2018; Orive et al., 2004; Rokstad et al., 2014). Alginate is a 
commonly used hydrogel in microencapsulation due to its excellent 
biocompatibility and low toxicity (Lee and Mooney, 2012; Zimmermann 
et al., 2007). To improve the stiffness of alginate-based microcapsules 
while maintaining low immunogenicity, microcapsules are subsequently 
coated with poly-L-lysine (PLL) and alginate (Orive et al., 2002; 
Virumbrales-Muñoz et al., 2021). The resulting microcapsule, known as 
alginate-PLL-alginate (APA) microcapsule, has been previously used to 
encapsulate CDCs, without affecting their viability and growth factor 
secretory capacity (Ziani et al., 2021). 
Although microencapsulation may significantly improve cell therapy 
effectiveness, hospitals and clinical facilities lack equipment and 
expertise to encapsulate cells. Therefore, clinical translation requires a 
robust long-term storage that preserves microcapsule structure and cell 
stability. Maintenance of therapeutic cells for long periods of time at 
37 ◦C incurs in high resource and manpower investments and can 
decrease the therapeutic abilities of cells overtime. Cryopreservation in 
liquid nitrogen is a well-established and easy procedure to store cells 
with good recovery rates. Although CDCs have been cryopreserved 
without altering their stem characteristics (Dutton et al., 2018), the ef-
fects of cryopreservation on encapsulated CDCs have not been reported 
yet. 
Most research in microencapsulation has focused on the effects of 
freezing on cells behaviour (Gurruchaga et al., 2018), without 
addressing structural alterations of the microcapsules. However, 
microcapsule topographical and mechanical properties are key factors to 
ensure the effectiveness of microencapsulated implants. Characteriza-
tion of these features in vitro can accelerate research, reducing validation 
prior to in vivo testing. Atomic Force Microscopy (AFM) is a powerful set 
of techniques to characterize surface properties. AFM is ideally suited to 
characterize microcapsule surface properties, since it provides nano-
metric resolution in physiologically relevant liquid media, and does not 
require significant sample preparation procedures that may impact 
microcapsule structure (Allison et al., 2010; Binnig et al., 1986; Lekka 
et al., 2004). Force spectroscopy-based measurements via AFM can 
provide both topographic and stiffness data of the microcapsule surface 
(Virumbrales-Muñoz et al., 2019). However, the small penetration 
ranges of AFM indentation, usually in the nanoscale, falls short in 
determining microcapsule overall stiffness. Large deformation assays, 
such as micromanipulation, aspiration, or microcapsule constriction, 
have been reported to measure whole microcapsule stiffness (Campillo 
et al., 2007; Kim et al., 2010; Le Goff et al., 2017; Neubauer et al., 2014). 
Therefore, combining AFM measurements with large deformation assays 
can provide a valuable overview of the most relevant microcapsule 
mechanical properties. In previous work, we applied for the first time an 
innovative workflow combining AFM Force Spectroscopy measurements 
with a custom-made constriction test to assess the mechanical properties 
of alginate-based microcapsules, (Virumbrales-Muñoz et al., 2021). 
In this manuscript, we study the long-term endurance of cultured and 
cryopreserved microencapsulated CDCs, assessing both the biological 
response of CDCs and the mechanical integrity of cultured and cry-
opreserved microcapsules after 30 and 60 days, respectively. CDCs 
viability, metabolic activity and VEGF release were quantified and 
microcapsule integrity was investigated by combining force 
spectroscopy-based AFM measurements of the surface and a constriction 
assay. 
2. Materials and methods 
2.1. Cell culture 
Cardiosphere derived cells (CDCs) were obtained from cardiac tissue 
explants of pigs. Tissue explants were subjected to enzymatic digestions 
and cultured. After three weeks, fibroblast-like cells migrating from the 
explant were seeded and cell clusters (i.e., cardiospheres) were formed. 
Cells migrating from these clusters (CDCs), were selected and expanded 
in standard cell culture flasks. 
CDCs were cultured in complete medium composed of 65% Dul-
becco’s Modified Eagle’s Medium (DMEM) Ham’s F12 with 3.996 mM 
Ultra Glutamine (Lonza, Switzerland) and 35% Iscove’s Modified Dul-
becco’s Medium (IMDM) (Lonza, Switzerland) supplemented with 10% 
FBS (Lonza, Switzerland), 1% Penicillin-Streptomycin (Lonza, 
Switzerland), 2 mM L-glutamine (Invitrogen), and 0.1 mM 2-mercaptoe-
thanol (Sigma Aldrich, United States). Cells were maintained at 37 ◦C in 
a humidified 5% CO2 atmosphere, and passaged every 2–3 days. 
2.2. Cell encapsulation 
Encapsulation was performed at room temperature, under aseptic 
conditions. UltraPure Low Viscosity High Guluronic, UPLVG, alginate 
(FMC Biopolymer, Norway) was resuspended in distilled water with 1% 
mannitol (Sigma Aldrich, Madrid, Spain) to obtain 1.5% (w/v) alginate 
and 0.1% alginate solutions. Final solutions were filtered through a 0.22 
µm syringe filter (Millipore, MA, USA). Then, CDCs were suspended in 
the 1.5% alginate solution, at a concentration of 5 × 106 cells/mL, and 
extruded with a peristaltic pump (flow rate: 5.9 mL/h) through an 
electrostatic atomization generator VARV1 (Nisco, Switzerland). 
The resulting alginate microcapsules were maintained in agitation 
for 15 min in a 55 mM CaCl2 solution (Sigma Aldrich, Madrid, Spain) for 
complete ionic gelation. Afterwards, they were coated with 0.05 % (w/ 
v) Poly-L-lysine, PLL (Sigma Aldrich, Madrid, Spain), by incubating with 
agitation during 5 min, followed by another coating step with 0.1% 
alginate for 5 min. The resulting microcapsules were divided in two 
groups. One group was maintained with complete medium at 37 ◦C, in a 
humidified 5% CO2 and 95% air atmosphere standard incubator, and 
was tested at 1, 7, 15 and 30 days after production. The second group 
was maintained with complete medium and 10% of DMSO at − 196 ◦C in 
liquid nitrogen and thawed at days 15, 30 and 60 after production. 
Thawed microcapsules were incubated for 24 h before testing. 
2.3. Microcapsule cryopreservation 
Microcapsules were stored in freshly prepared complete medium 
with 10% DMSO (ATCC), hereafter called cryoprotective solution. 200 
μL of microcapsules containing CDCs were resuspended in cryovials 
(Nalgene) with 1 mL of the cryoprotective solution previously prepared. 
Cryovials were frozen at − 80 ◦C for one day on a Nalgene Cryo 
container and stored in liquid nitrogen tanks the following day. After 15, 
30 and 60 days, cryovials were completely thawed by immersion in a 
37 ◦C bath. Cryopreserved microcapsules were rinsed three times with 
10 mL of complete medium to remove the remaining cryoprotectant 
solution and incubated for 24 h before testing. 
2.4. Metabolic activity assay 
Metabolic activity was determined with the Cell Counting Kit-8, 
CCK-8 (SigmaAldrich, United States), per manufacturer’s instructions. 
25 μL of microcapsule solution was rinsed, resuspended into 500 μL of 
culture medium supplemented with 50 μL of CCK-8 reagent, and plated 
in 5 wells of a 96-well plate. After incubation for 4 h at 37 ◦C, absorbance 
was measured on an Infinite M200 TECAN plate reader (TECAN Trading 
AG, Switzerland) at 450 nm and corrected at 650 nm. At least three 
independent experiments were analyzed for each day. 
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2.5. VEGF quantification 
To quantify VEGF secretion, 500 µL of microcapsule supernatant 
were collected and stored at − 80 ◦C for subsequent processing. Levels of 
VEGF within the supernatants were determined with VEGF ELISA Kit 
(My BioSource, Inc.), per manufacturer’s instructions. Absorbance was 
measured at 450 nm on an Infinite M200 TECAN plate reader (TECAN 
Trading AG, Switzerland) and VEGF concentration was calculated from 
a standard curve. We performed at least three independent experiments, 
with three technical replicates per condition. 
2.6. Cell viability 
Microencapsulated cell viability was assessed after calcein AM/ 
ethidium homodimer staining. Briefly, 50 μL of microcapsules were 
rinsed three times in DPBS (Gibco, United States) and resuspended in 
500 μL of 0.5 μM ethidium homodimer-1 (Life Technologies, United 
States) and 0.5 μM calcein AM (Life Technologies, United States) solu-
tion. The samples were incubated in 24-well-plates for 45 min at room 
temperature, protected from light. Samples were observed under a 
Nikon Eclipse TE2000-S confocal microscope at 470 nm wavelength for 
calcein AM and 575 nm wavelength for ethidium homodimer staining. 
Random images were analyzed with the NIS Elements AR software, 
version 4.51.00. At least three independent experiments were performed 
for each condition. 
2.7. Microcapsule constriction assay 
Global microcapsule stiffness was determined using a custom-made 
constriction system described previously (Virumbrales-Muñoz et al., 
2021). Briefly, measurements were performed within a methacrylate 
microfluidic device designed by BeOnChip S.L. (Spain) and manufac-
tured by Aitiip Centro Tecnológico (Spain). This microdevice consisted 
of a Ø400 μm tubular channel, sharply reduced to Ø 200 μm. A 1/16′′OD 
PTFE (Elveflow, France) and a TYGON (Saint-Gobain, ACF00002-C) 
tubing system were used to connect the microdevice to a pressure 
controller (OB1 Microfluidic Flow Control System, Elveflow). Optical 
inspection of the microfluidic channel was performed by an optical 
inverted microscope (Leica DMi8). 
2.7.1. Constriction measurements 
The constriction system was perfused with culture media or DPBS. 
Microcapsules diluted in culture media were individually isolated in a U- 
shape 96-well plate (Sarstedt) for optical microscopy inspection (Nikon- 
Eclipse Ti-E). After measuring microcapsule diameter with NIS Elements 
Analysis Software (Nikon), each microcapsule was captured with a 
micropipette and injected into the system. Pressure lower than 1000 Pa 
was applied to place the microcapsule at the entrance of the micro-
channel constriction. Then, the pressure was increased at a constant rate 
of 100 Pa/s, pushing the microcapsule through the constriction. The 
microscopic optical image of the microdevice and the pressure mea-
surements were video recorded during the whole process for posterior 
analysis. At least 10 microcapsules per condition were tested. 
2.7.2. Stiffness calculation from constriction data 
The stiffness of microcapsules was determined as a pressure/defor-
mation relationship (ΔP/Δδ). To obtain this relationship, videos of the 
constriction assay were processed using VLC media player software. 
After each 10-mbar pressure increment, the corresponding video frame 
was exported as an image file. The length occupied by the microcapsule 
in the Ø 200 μm channel was measured for each exerted pressure 
(ImageJ software) and normalized by the initial microcapsule diameter 
to calculate deformation. For small deformations, experimental results 
could be fitted to a linear curve from which the pressure/deformation 
relationship was obtained. 
2.8. AFM measurements 
Topographical and mechanical measurements of the microcapsule 
surface were performed by an AFM Nanowizard 3 system (JPK In-
struments, Germany) mounted on an optical inverted microscope 
(Nikon-Eclipse). 
2.8.1. Tip calibration 
AFM measurements were performed with qpBioAC-CI probes 
(NanoANdMore GMBH). The pyramidal shape of these probes’ tips 
makes them suitable for high resolution imagining. Tip CB1 was chosen 
due to the adequacy of its nominal spring constant (0.3 N⋅m− 1) for 
samples in the kPa scale, such as APA microcapsule formulation 
(Virumbrales-Muñoz et al., 2019). The experimental spring constant of 
each new tip used was characterized by the Thermal Noise Method 
before performing any measurements (Hutter and Bechhoefer, 1993). 
2.8.2. Microcapsules sample preparation 
Microcapsules were immobilized within a Ø 330 nylon mesh (Lab-
opolis S.L.) to perform the AFM measurements in liquid. Mesh was glued 
in a Petri Dish (TPP Techno Plastic Products AG, 93040) using a stan-
dard 2-component cyanoacrylate adhesive. Then, the Petri Dish was 
filled with culture media, and bubbles lodged within the mess were 
dislodged via repeated pipetting. The dish was placed on the Petri-
DishHeater (JPK Instruments, Germany) stage to reach a stable tem-
perature of 37 ◦C. A sterile aliquot of microcapsules suspended in culture 
media was added to the Petri Dish, allowing microcapsules to sediment 
and locate within the mesh openings. 
2.8.3. Force spectroscopy measurements 
Force spectroscopy-based images were acquired using the AFM 
Quantitative Imagining (QI) mode, as previously described (Virum-
brales-Muñoz et al., 2019). Briefly, the calibrated cantilever was posi-
tioned over a mesh-immobilized microcapsule. High Z-lengths (2 µm), 
slow speeds (10 µm⋅s − 1) and low resolution (8x8 pixel size) were used 
to obtain the initial QI maps. Once stable measurements with a high 
signal/noise ratio were achieved, parameters were optimized for quicker 
(120 µm⋅s − 1) high resolution (256x256 pixel) imaging. Z-length was 
decreased to the nm scale to minimize sample drift effects during the 
acquisition but programmed to at least double the image height. For 
each microcapsule, two high resolution maps of 9 µm2 and one high 
resolution map of 100 µm2 were acquired. At least 10 microcapsules per 
condition were analyzed. 
2.8.4. AFM image processing 
QI maps (golden color scale) were processed by DP software (JPK 
Instruments, Germany). From each map, a height image was extracted. 
Raw images were flattened by fitting to a second order polynomial line, 
to highlight small features in the overall curved surface. Then, a small 
degree of smoothing was applied to render pixel transition less evident. 
2.8.5. Young’s Moduli extraction 
Force spectroscopy curves, acquired as pixels of the QI maps, were 
processed by DP Software (JPK Instruments, Germany) to obtain 
Young’s Moduli. Curves were fitted to a Hertz model modified for pa-
raboloid indentors (JPK Instruments, 2008). Calculated values were 
shown as a blue color scale map. 
2.8.6. Bidimensional statistics 
Topographical images were analyzed with Gwyddion open-source 
software to calculate bidimensional statistical parameters (i.e., 
Maximum Image Height, RMS, Ra, Skewness index and Kurtosis index) 
(Nečas and Klapetek, 2012). 
L. Paz-Artigas et al.                                                                                                                                                                                                                            
International Journal of Pharmaceutics 607 (2021) 121014
4
2.9. Statistical analysis 
GraphPad Prism 6 software was used for the statistical analysis of all 
parameters. Data were expressed as mean ± standard deviation. Statis-
tically significant differences were determined using ANOVA, Post Hoc 
Dunnett’s multiple comparison test when data followed a normal dis-
tribution and Mann Whitney test for non-Gaussian data. Normal distri-
bution was determined by Shapiro-Wilk normality test. 
Fig. 1. Biochemical profile of encapsulated Cardiosphere-Derived-Cells (CDCs) cultured at 37 ◦C over a month. (A) Optical images of life-death assay, where alive 
cells were stained with calcein AM (green) and dead cells were stained with ethidium homodimer (red). (B) Metabolic activity of CDCs via CCK-8 assay. (C) Release 
profile of VEGF. Bars represent mean ± SD. **: p < 0.01 and *: p < 0.05 compared to day 1. 
Fig. 2. Stiffness determination of Alginate-Poly-L- 
lysine-Alginate (APA) microcapsules loaded with 
Cardiosphere-Derived-Cells (CDCs) cultured at 
37 ◦C for 30 days. (A) Graphic representation of the 
Atomic Force Microscopy (AFM) determination of 
microcapsules Young Modulus. Force-spectroscopy 
curves were acquired by indentation over the 
microcapsule surface and processed to obtain stiff-
ness maps. (B) Average values of Young Modulus 
obtained from AFM stiffness maps. (C) Schematic 
representation of the constriction assay. Microcap-
sules were subjected to an increasing pressure, P, 
and forced to penetrate within a narrow micro-
fluidic channel. Pressure data was then plotted 
against deformation, δ. For small penetrations, the 
pressure/deformation ratio remained constant. (D) 
Stiffness calculated as pressure/deformation ratio 
from constriction assay. Bars represent mean ± SD. 
n = at least 10 microcapsules. ***: p < 0.001 and **: 
p < 0.01 compared to day 1.   
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3. Results and discussion 
3.1. Encapsulated CDCs in culture have lower viability and VEGF release 
overtime 
We investigated the effects of long-term culture on encapsulated 
cardiosphere-derived cells (CDCs) (Ziani et al., 2021). To this end, CDCs 
were immobilized within spherical alginate-based gels double coated 
with poly-L-lysine and alginate. We used ultrapure low viscosity and 
high guluronic alginate, since animal implantation of high purity algi-
nate gels do not to induce significant foreign body reaction (Lee and Lee, 
2009; Orive et al., 2002). Resulting microcapsules, known as alginate- 
poly-L-lysine-alginate (APA) microcapsules, presented an average size 
of 420 µm (Supplemental Fig. 1) and were incubated in culture media at 
37 ◦C for 30 days. 
Cell viability (Fig. 1A) improved during the first 7 days after 
encapsulation, suggesting an adaptation process to the hydrogel matrix 
microenvironment, as reported for other cell types, such as MSCs (Ciriza 
et al., 2018; Ziani et al., 2021). However, a certain cell death, already 
detected at day 15, became evident 30 days after encapsulation, as 
shown by fluorescence microscopy images of encapsulated CDCs stained 
with calcein/ethidium homodimer. Similarly, metabolic activity 
(Fig. 1B) inverted its initial tendency at day 15 and continued decreasing 
to almost half its initial value after 30 days of culture, as measured via 
CCK8-based assay. We next assessed the regenerative potential of 
encapsulated CDCs by quantifying VEGF release (Fig. 1C), which also 
showed a significant reduction from 15 days forward. While a high cell 
growth would be counterproductive since it can lead to microcapsule 
breakage (Orive et al., 2003), the cell progressive deterioration after 15 
days of culture at 37 ◦C warns against long-term storage of encapsulated 
CDCs at this in vitro culture conditions. 
3.2. Microcapsule core of encapsulated CDCs suffers alterations over time 
at 37◦, while surface topography and stiffness remain unchanged 
It is well known that stiffness and mechanical stability of scaffolds 
have a great impact on cells performance in 3D cultures (Breuls et al., 
2008; Mason et al., 2013; Petersen et al., 2012; Sasikumar et al., 2019). 
In fact, CDCs maturation has been proved to depend on scaffold stiffness 
(Xu et al., 2014). Therefore, we investigated whether the observed CDCs 
viability, metabolic activity and VEGF release profiles were related to 
microcapsules mechanical stability. Force Spectroscopy via Atomic 
Force Microscopy (AFM) allows the fine determination of hydrogels and 
soft materials Young’s Modulus (Garcia, 2020; Giménez et al., 2017) and 
Fig. 3. Topographical analysis of the microcapsule 
surface via Atomic Force Microscopy (AFM) per-
formed. (A) Topography images of the microcapsule 
surface were acquired by AFM and characterized 
with standard topography parameters: Maximum 
Image Height (MIH), RMS roughness, Ra roughness, 
Skewness index and Kurtosis index. The example 
line profiles illustrate the physical significance of 
each parameter. Skewness and Kurtosis index are 
dependent on height frequency distribution. (B) 
Standard topography parameters determined from 
9 µm2 detailed images. Bars show mean ± SD. n =
at least 10 microcapsules. **: p < 0.01 and *: p <
0.05 compared to day 1.   
L. Paz-Artigas et al.                                                                                                                                                                                                                            
International Journal of Pharmaceutics 607 (2021) 121014
6
has been used for microcapsules mechanical characterization in physi-
ological conditions (in liquid at 37 ◦C) (Chui et al., 2019; Ciriza et al., 
2015; Fery et al., 2004; Sarrazin et al., 2016; Virumbrales-Muñoz et al., 
2021). Therefore, we scanned square areas of microcapsules surface 
(Fig. 2A) by AFM’s tip indentation, obtaining force-spectroscopy curves 
that were fitted to the Hertz model and generating maps of the micro-
capsule surface stiffness. Young Modulus mean values obtained from 
these maps (Fig. 2B) did not change overtime for microcapsules incu-
bated at 37 ◦C. 
Since AFM is meant for the characterization of material surfaces, we 
complemented AFM measurements with a constriction assay test 
(Fig. 2C) previously reported by our group (Virumbrales-Muñoz et al., 
2021). In this test microcapsules (diameter of 400 µm) are forced to cross 
through a narrow microfluidic channel (diameter of 200 µm), assessing 
the resistance of the microcapsule to large deformations, and therefore 
providing a macro mechanical measurement of stiffness. Determining 
the elastic modulus of microcapsules from large deformation assays is 
challenging, since a great range of strains and stresses are involved. To 
accurately report microcapsule elastic modulus from this assay, a com-
plex and exhaustive simulation of the whole process (e.g., via finite el-
ements) would be needed. However, since our goal is to investigate 
significant alterations of microcapsule stability through time, a simpler 
approach can be used to estimate microcapsule stiffness. As previously 
reported (Le Goff et al., 2017; Virumbrales-Muñoz et al., 2021), the 
pressure/deformation ratio, where deformation is represented by the 
microcapsule penetration length inside the narrow channel, may serve 
as a reliable parameter to compare stiffness of different microcapsules. 
Microcapsule stiffness characterized via our constriction assay showed a 
constant decrease overtime with significant differences at day 15 of 
incubation, which became more evident after 30 days in culture at 37 ◦C 
(Fig. 2D). It must be noted that the constant obtained from this assay 
does not represent the elastic modulus and, thus, both stiffness mea-
surements (Fig. 2B and D) should not be compared in terms of absolute 
values, but tendencies through time. 
We previously observed that APA microcapsules show not only sur-
face Young Modulus 30-fold higher than nude alginate microcapsules, 
but also 2-fold higher constriction stiffness (Virumbrales-Muñoz et al., 
2021), therefore suggesting an important contribution of alginate-PLL 
double coating to the general stiffness characterized by constriction 
assay. Since surface Young Modulus remains unaltered after 30 days in 
cultured APA microcapsules, we can conclude that the observed time- 
dependent decrease in APA constriction stiffness is probably related to 
changes in the alginate core instead of the coating. Therefore, PLL 
coating would help keeping the shape and surface mechanical properties 
of microcapsules overtime. In fact, alginate-based microcapsules culture 
within saline medium has proved to cause degradation of their structure 
integrity, probably due to an ion exchange with Ca2+ ions in the cross- 
linked alginate, which is not observed when microcapsules are pre-
served in free-ion water (Bajpai and Sharma, 2004; Hunt et al., 2010; 
LeRoux et al., 1999; Moya et al., 2012). Notably, viability, metabolic 
Fig. 4. Biochemical behaviour of encapsulated 
Cardiosphere-Derived-Cells (CDCs) after cryopres-
ervation. Cells were frozen one day after encapsu-
lation, thawed after their corresponding 
cryopreservation period and incubated at 37 ◦C in 
culture media 24 h before performing any assay. (A) 
Metabolic activity of CDCs via CCK-8 assay. (B) 
Release profile of Vascular Endothelial Growth 
Factor (VEGF). (C) Optical images of a life-death 
assay, where alive cells were stained with calcein 
(green) and dead cells were stained with ethidium 
homodimer (red). Bars show mean ± SD. ***: p <
0.001 comparing cryopreservation vs incubation at 
37 ◦C. ††: p < 0.01 compared to day 15 of 
cryopreservation.   
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activity and VEGF release of encapsulated CDCs presented a similar 
tendency to global microcapsule stiffness. These combined results sug-
gest a relationship between the loss of integrity of the microcapsule core 
and the alterations of the cell’s behaviour through time, while the 
double coating of the surface may remain unaltered. 
Since the main purpose of cell encapsulation is concealing the ther-
apeutic cells from the host immune surveillance, producing robust mi-
crocapsules that maintain a stable and non-immunogenic surface is key 
to therapy success. Thus, we pursued the characterization of micro-
capsule surfaces by investigating its topographical features through 
AFM (Fig. 3A). From each force-spectroscopy curve, the sample height 
was obtained and depicted as a pixel of a topographic map. We acquired 
large maps of 100 µm2 (Supplemental Fig. 2) to verify the homogeneity 
of the microcapsule surfaces and detailed maps of 9 µm2 (Fig. 3B) to 
increase the resolution of the topographical features. Classical parame-
ters established by ISO standards (International Organisation of Stan-
dardization, 2012) for topography quantitative analysis of material 
surfaces are Maximum Image Height (MIH), RMS, Ra, Skewness index 
and Kurtosis index (Fig. 3A) (Bonyar, 2015; Duboust et al., 2017; Kun-
drak et al., 2008; Petrochenko et al., 2015). MIH represents the absolute 
distance between the highest peak and the lowest pore within the entire 
image. RMS and Ra parameters quantify surface deviation from a flat 
plane, determining surface roughness. Ra is calculated as the average 
distance that the surface deviates from the flat plane, while RMS is ob-
tained from the area enclosed between these two elements. Surface 
asymmetry is determined by the Skewness index, with positive values 
when peaks emerge from an overall flat surface, and negative values 
when valleys are more prominent. Finally, the sharpness of peaks is 
calculated by the Kurtosis index, with high values of Kurtosis repre-
senting a very sharp surface and low values, rounded profiles. Detailed 
topography maps of CDCs-loaded microcapsules (Fig. 3B) showed a 
small increase of MIH at day 7, recovering initial values at day 15. Mi-
crocapsules presented similar roughness profiles in both Ra and RMS. 
After 7 days of incubation, surface roughness increased, reducing at day 
15 and recovering initial values after 30 days, similar tendency than 
encapsulated CDCs viability and metabolic activity (Fig. 1). These var-
iations in MIH and roughness could be related to CDCs growth and 
protrusion, since there is a relationship between cell growth and 
microcapsule roughness increase, without alteration of the surface 
roughness in empty capsules (Bhujbal et al., 2014). Regarding surface 
asymmetry, microcapsule surface remained with constant Skewness 
index during the whole period of incubation, with positive values, 
suggesting the predominance of peaks instead of a more porous surface. 
Similar to Skewness, no variations on Kurtosis index were detected 
overtime, indicating no changes on microcapsule surfaces peaks shape. 
Overall, microcapsule surface remained stable after 30 days of in-
cubation at 37 ◦C, characterized by the presence of peaks with slightly 
sharp shape, with an initial increase in roughness, which was progres-
sively reduced, but not affecting neither the peak sharp shape, nor the 
local stiffness of the microcapsule surface. However, microcapsule 
global stiffness and encapsulated CDCs suffered alterations after 15 days 
of culture, which became more severe at day 30. Those tendencies 
suggest that longer periods of incubation at 37 ◦C could render an 
ineffective therapy of encapsulated CDCs if grown at 37 ◦C patient 
implantation. 
3.3. Microcapsule surface of encapsulated CDCs suffers slight alterations 
after 15 days on cryopreservation, while core remains stable 
Cryopreservation is a well-established method for the long-term 
storage of cells and biological samples, reducing cost and facilitating 
the storage and transport of encapsulated cells from research labora-
tories to clinical facilities. In fact, the combination of classical cry-
oprotectors, such as DMSO, and cell immobilization within alginate or 
other hydrogel matrix has proven to enhance the cryoprotective effect in 
several cell types (Gurruchaga et al., 2018; Malpique et al., 2010; Mat-
sumoto et al., 2001). However, to facilitate clinical implementation of 
cryopreserved encapsulated cells, viability and capsule stability should 
not be significantly affected by this procedure. As a framework for 
comparison, we used microcapsules incubated at 37 ◦C and compared 
the effects of culture at 37 ◦C versus cryopreservation on encapsulated 
CDCs properties at both 15 and 30 days. For cryopreservation, micro-
capsules were frozen 24 h after CDCs encapsulation, maintained in 
liquid nitrogen, thawed at the mentioned days, and kept in culture at 
37 ◦C during another 24 h before inspection. Since cryopreservation is 
meant for long-term storage, we also analyzed the effects of 60 days of 
cryopreservation and compare it to shorter cryopreservation times. 
Metabolic activity of encapsulated CDCs (Fig. 4A) after 15 days of 
cryopreservation plummeted compared to counterparts maintained at 
37 ◦C. This decrease seemed to be related to the frozen process itself, as 
longer periods of cryopreservation were not translated to lower meta-
bolic activity. Conversely, this parameter tended to improve with longer 
cryopreservation periods, being significantly higher after 60 days of 
cryopreservation, compared to 15 days. Moreover, at day 30 no signif-
icant differences were detected in metabolic activity between cultured 
and cryopreserved microcapsules. The tendency of metabolic activity 
suggested that better metabolic activities are achieved by cryopreserv-
ing than culturing in storage periods longer than 15 days. Quantifying 
the release of VEGF, no significant differences were detected among 
cryopreserved and cultured encapsulated CDCs overtime, remaining 
constant for 60 days (Fig. 4B). Similarly, cell viability was not affected 
by cryopreservation time (Fig. 4C). Therefore, we consider that although 
encapsulated CDCs viability is optimal during 7 days cultured at 37 ◦C, 
cryopreservation seems to better preserve cell properties at longer 
storage periods. In fact, non-encapsulated CDCs have previously been 
cryopreserved without significant changes in their stem profile (Dutton 
et al., 2018), in accordance with our data with encapsulated CDCs. 
We next assessed the effects of cryopreservation on the mechanical 
stability of APA microcapsules. We determined both Young Modulus of 
microcapsule surface by means of AFM (Fig. 5A), and overall stiffness by 
constriction assay (Fig. 5B). The constriction assay revealed no changes 
in stiffness overtime for the cryopreserved capsules, with higher values 
than their counterparts at 37 ◦C. These results suggest that the degra-
dation of alginate gel caused by the exchange of calcium ions that cross- 
Fig. 5. Effect of cryopreservation on the stiffness of 
Alginate-Poly-L-lysine-Alginate (APA) microcap-
sules loaded with Cardiosphere-Derived-Cells 
(CDCs). (A) Microcapsule Young’s Moduli obtained 
from force spectroscopy measurements via Atomic 
Force Microscopy (AFM). (B) Stiffness of microcap-
sule calculated as the pressure/deformation ratio 
from constriction assay. Bars represent mean ± SD. 
n = at least 10 microcapsules. ***: p < 0.001 
comparing cryopreservation vs incubation at 37 ◦C.   
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link the structure with ions of the medium during culture is avoided 
when microcapsules are cryopreserved. While surface stiffness remained 
unchanged during incubation at 37 ◦C, cryopreservation reduced Young 
Modulus as determined by AFM, suggesting that freezing procedure 
affects microcapsule coating. However, when compared to its counter-
part, no significant differences in Young’s Moduli were detected after 30 
days of cryopreservation. We can conclude that long term storage of 
encapsulated CDCs provides lower alteration of microcapsule mechan-
ical stability than culture at 37 ◦C, with similar surface stiffness. 
Regarding microcapsules topography (Fig. 6), cryopreservation had 
no significant effect on MIH compared to microcapsules culture at 37 ◦C. 
Similarly, the roughness of cryopreserved microcapsules determined by 
RMS and Ra showed no significant differences to their counterparts at 15 
and 30 days. However, RMS and Ra data revealed surface roughness to 
have the opposite tendency on cryopreserved microcapsules than on 
cultured at 37 ◦C (Fig. 3), with a significant decrease when comparing 
days 30 and 60 to day 15 of cryopreservation, suggesting a smoothing of 
microcapsule surfaces caused by long-term cryopreservation. While no 
roughness increase caused by cell growth and protrusion is expected for 
cryopreserved microcapsules, the smoothing of the surface is harder to 
explain. APA microcapsules are known to have a relative smooth sur-
face, since poly-L-lisine (PLL) single coating (AP microcapsules) 
(Virumbrales-Muñoz et al., 2019) or PLL and alginate double coating 
(APA microcapsules) (Virumbrales-Muñoz et al., 2021) have proved to 
reduce surface roughness of alginate microcapsules. An increase in 
smoothness can be achieved by adding a new coating of PEG-Amine 
(Chen et al., 1998). However, cryopreservation process is not expected 
to cause any chemical modification of the microcapsule coating. In PLL 
coated capsules, surface roughness is also reduced by chelation of the 
inner alginate hydrogel (Gattás-Asfura et al., 2014), but cryopreserva-
tion caused no alteration of the alginate core, as reported by constriction 
assay. To our knowledge, there are no studies on APA microcapsule 
degradation processes that could clarify the possible causes of the sur-
face smoothing observed during cryopreservation of encapsulated CDCs. 
Finally, Skewness and Kurtosis indexes showed no significant differ-
ences between cultured and cryopreserved microcapsules at any time 
point of analysis. Only Kurtosis showed a significant increase after 60 
days compared to 15 days of cryopreservation and, even so, this value 
was comparable to Kurtosis of microcapsules cultured at 37 ◦C during 
30 days. Cryopreserved microcapsule surfaces kept the same tendency to 
peaks and slightly sharp contours than their cultured counterparts. 
In brief, mechanical analysis of CDCs-loaded APA microcapsules has 
shown that cryopreservation has no effect on the microcapsule core, 
while slightly reducing surface stiffness and roughness. Although further 
investigation may be necessary to characterize the physicochemical ef-
fects of cryopreservation on microcapsule surfaces, our results are 
promising, since a smooth surface of biomaterials has been related to 
low response after implantation (Bhujbal et al., 2014; Bünger et al., 
2003; de Vos et al., 2006; Li et al., 2018). 
4. Conclusions 
We have investigated for the first time the mechanical alterations of 
cell-loaded microcapsules after cryopreservation, combining topo-
graphical and mechanical characterization of microcapsules. Our results 
show that functionality of encapsulated CDCs, as assessed via metabolic 
activity, viability and secretory capacity of cells, is optimum after 7 days 
of culture at 37 ◦C, maintaining topographical and mechanical proper-
ties of freshly produced microcapsules. However, cryopreservation 
seems to better guarantee the stability of both CDCs and APA micro-
capsules properties in long-term storage. While further investigation on 
in vivo effects of cryopreservation on microcapsules is necessary, such as 
microcapsule recognition by the immune system, our results predict a 
promising translation to clinics of cryopreservation for encapsulated 
CDCs therapy, which would reduce time and resources requirements for 
hospitals and health facilities. 
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F., Hare, J.M., 2018. Preclinical Studies of Stem Cell Therapy for Heart Disease. Circ. 
Res. 122, 1006–1020. https://doi.org/10.1161/CIRCRESAHA.117.312486. 
Van Ramshorst, J., Rodrigo, S.F., Schalij, M.J., Beeres, S.L.M.A., Bax, J.J., Atsma, D.E., 
2011. Bone marrow cell injection for chronic myocardial ischemia: The past and the 
future. J. Cardiovasc. Transl. Res. https://doi.org/10.1007/s12265-010-9249-8. 
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